Morgan Stanley Reiterates Equal-Weight on Hologic, Maintains $86 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Tejas Savant has reiterated an Equal-Weight rating on Hologic (NASDAQ:HOLX) and maintained a price target of $86.
August 04, 2023 | 9:29 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley has reiterated an Equal-Weight rating on Hologic, maintaining a price target of $86.
The news is directly about Hologic and is likely to influence investor sentiment. However, as the rating and price target have been maintained, the impact on the stock price is expected to be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100